Quarterly report pursuant to Section 13 or 15(d)

SHARE BASED PAYMENTS

v3.22.2
SHARE BASED PAYMENTS
6 Months Ended
Jun. 30, 2022
Share-Based Payment Arrangement [Abstract]  
SHARE BASED PAYMENTS SHARE BASED PAYMENTS
 
The Company maintains long-term incentive plans for employees, non-employee members of our Board of Directors and consultants. The plans allows us to grant equity-based compensation awards, including stock options, stock appreciation rights, performance share units, restricted stock units, restricted stock awards, or a combination of awards (collectively, share-based awards).
 
The Company accounts for share-based payments through the measurement and recognition of compensation expense for share-based payment awards made to employees and directors of the Company, including stock options and restricted shares. The Company also issues share based payments in the form of common stock warrants to non-employees.
 
The following table presents share-based payment expense for the six months ended June 30, 2022 and 2021:
 
  Six months ended June 30,
  2022 2021
Restricted stock $ 1,951  $ 1,935 
Stock options 59  559 
Warrants 679  747 
Total $ 2,689  $ 3,241 
  
As of June 30, 2022, the Company had approximately $7.6 million of unamortized share-based compensation for option awards and restricted stock awards, which is expected to be recognized over a weighted average period of approximately 3.5 years. As of June 30, 2022, the Company also had approximately $1.9 million of unamortized share-based compensation for common stock warrants issued to consultants, which is expected to be recognized over a weighted average period of 1.5 years.
 
Restricted Stock
 
The Company issues shares of restricted stock to eligible employees, which are subject to forfeiture until the end of an applicable vesting period. The awards generally vest on the first, second, third, or fourth anniversary of the date of grant, subject to the employee’s continuing employment as of that date. Restricted stock is valued using market value on the grant date.
 
Restricted stock activity for the six months ended June 30, 2022 is presented in the following table:
 
  Shares Weighted Average Grant Date Fair Value
Nonvested, December 31, 2021
483,750  $ 20.19 
Granted 611,500  $ 10.76 
Vested (279,500) $ 9.94 
Forfeited (304,500) $ 17.51 
Nonvested, June 30, 2022
511,250  $ 18.36 
 
The table below summarizes all option activity under all plans during the six months ended June 30, 2022:
 
Options Shares Weighted -
Average
Exercise
Price
Weighted -
Average
Remaining
Contractual
Term
Weighted -
Average
Grant Date
Fair Value
Outstanding at December 31, 2021
906,425  $ 4.38  2.85 $ 2.45 
Granted —  —  —  — 
Exercised (26,000) 4.14  —  1.92 
Forfeited or expired (197,427) 5.68  —  3.19 
Outstanding at June 30, 2022
682,998  $ 4.00  2.32 $ 2.24 
Options vested at June 30, 2022
688,998  $ 4.00  2.32 $ 2.24 
   
A summary of the status of the Company’s outstanding stock purchase warrants for the six months ended June 30, 2022 is as follows:
 
  Warrants Weighted Average
Exercise Price
Outstanding at December 31, 2021
330,884  $ 22.14 
Issued —  — 
Exercised (48,387) 3.50 
Forfeited —  — 
Outstanding at June 30, 2022
282,497  $ 25.33